Mesa Laboratories, Inc. (MLAB)
MLAB Stock Price Chart
Explore Mesa Laboratories, Inc. interactive price chart. Choose custom timeframes to analyze MLAB price movements and trends.
MLAB Company Profile
Discover essential business fundamentals and corporate details for Mesa Laboratories, Inc. (MLAB) to support your stock research and investment decisions.
Sector
Technology
Industry
Hardware, Equipment & Parts
IPO Date
29 Feb 1984
Employees
736.00
Website
https://www.mesalabs.comCEO
Gary M. Owens
Description
Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. Its Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enables to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The company's Calibration Solutions segment designs, manufactures, and markets quality control and calibration products to measure or calibrate temperature, pressure, pH, humidity, and other such parameters used for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory and healthcare environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. Its Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in several therapeutic areas, such as newborn screenings, pharmacogenetics, and oncology. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.
MLAB Financial Timeline
Browse a chronological timeline of Mesa Laboratories, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 26 May 2026
Upcoming earnings on 2 Feb 2026
Upcoming earnings on 6 Nov 2025
EPS estimate is $2.59, while revenue estimate is $60.73M.
Earnings released on 5 Aug 2025
EPS came in at $2.32 falling short of the estimated $2.46 by -5.69%, while revenue for the quarter reached $59.54M , missing expectations by -1.42%.
Dividend declared on 3 Jul 2025
A dividend of $0.16 per share was announced, adjusted to $0.16. The dividend will be paid on 15 Sept 2025.
Earnings released on 28 May 2025
EPS came in at $2.23 falling short of the estimated $2.75 by -18.91%, while revenue for the quarter reached $62.14M , beating expectations by +0.38%.
Dividend declared on 7 Apr 2025
A dividend of $0.16 per share was announced, adjusted to $0.16. The dividend was paid on 16 Jun 2025.
Earnings released on 4 Feb 2025
EPS came in at $2.67 surpassing the estimated $1.41 by +89.36%, while revenue for the quarter reached $62.84M , beating expectations by +2.12%.
Dividend declared on 6 Jan 2025
A dividend of $0.16 per share was announced, adjusted to $0.16. The dividend was paid on 17 Mar 2025.
Earnings released on 7 Nov 2024
EPS came in at $2.45 falling short of the estimated $2.48 by -1.21%, while revenue for the quarter reached $57.83M , missing expectations by -0.08%.
Dividend declared on 2 Oct 2024
A dividend of $0.16 per share was announced, adjusted to $0.16. The dividend was paid on 16 Dec 2024.
Earnings released on 5 Aug 2024
EPS came in at $2.83 surpassing the estimated $2.33 by +21.46%, while revenue for the quarter reached $58.17M , beating expectations by +4.36%.
Dividend declared on 8 Jul 2024
A dividend of $0.16 per share was announced, adjusted to $0.16. The dividend was paid on 16 Sept 2024.
Earnings released on 5 Jun 2024
EPS came in at $2.77 surpassing the estimated -$0.11 by +2.62K%, while revenue for the quarter reached $58.90M , beating expectations by +6.57%.
Dividend declared on 2 Apr 2024
A dividend of $0.16 per share was announced, adjusted to $0.16. The dividend was paid on 14 Jun 2024.
Earnings released on 5 Feb 2024
EPS came in at $2.02 falling short of the estimated $2.04 by -0.98%, while revenue for the quarter reached $53.47M , missing expectations by -0.98%.
Dividend declared on 2 Jan 2024
A dividend of $0.16 per share was announced, adjusted to $0.16. The dividend was paid on 15 Mar 2024.
Earnings released on 6 Nov 2023
EPS came in at $1.91 surpassing the estimated $1.65 by +15.76%, while revenue for the quarter reached $53.17M , missing expectations by -2.72%.
Dividend declared on 3 Oct 2023
A dividend of $0.16 per share was announced, adjusted to $0.16. The dividend was paid on 15 Dec 2023.
Earnings released on 3 Aug 2023
EPS came in at $1.77 surpassing the estimated $1.67 by +5.99%, while revenue for the quarter reached $50.65M , missing expectations by -2.32%.
Dividend declared on 5 Jul 2023
A dividend of $0.16 per share was announced, adjusted to $0.16. The dividend was paid on 15 Sept 2023.
Earnings released on 25 May 2023
EPS came in at $1.94 falling short of the estimated $1.98 by -2.02%, while revenue for the quarter reached $55.59M , missing expectations by -3.15%.
Dividend declared on 3 Apr 2023
A dividend of $0.16 per share was announced, adjusted to $0.16. The dividend was paid on 15 Jun 2023.
Earnings released on 6 Feb 2023
EPS came in at $2.35 surpassing the estimated $2.10 by +11.90%, while revenue for the quarter reached $54.29M , missing expectations by -4.83%.
Dividend declared on 3 Jan 2023
A dividend of $0.16 per share was announced, adjusted to $0.16. The dividend was paid on 15 Mar 2023.
Earnings released on 3 Nov 2022
EPS came in at $2.88 surpassing the estimated $1.39 by +107.19%, while revenue for the quarter reached $58.75M , beating expectations by +10.35%.
Dividend declared on 3 Oct 2022
A dividend of $0.16 per share was announced, adjusted to $0.16. The dividend was paid on 15 Dec 2022.
Earnings released on 4 Aug 2022
EPS came in at $1.17 falling short of the estimated $1.95 by -40.00%, while revenue for the quarter reached $50.45M , missing expectations by -3.30%.
Dividend declared on 6 Jul 2022
A dividend of $0.16 per share was announced, adjusted to $0.16. The dividend was paid on 15 Sept 2022.
Earnings released on 31 May 2022
EPS came in at $2.22 surpassing the estimated $1.88 by +18.09%, while revenue for the quarter reached $58.88M , beating expectations by +4.42%.
Dividend declared on 6 Apr 2022
A dividend of $0.16 per share was announced, adjusted to $0.16. The dividend was paid on 15 Jun 2022.
Earnings released on 3 Feb 2022
EPS came in at $1.36 falling short of the estimated $1.68 by -19.05%, while revenue for the quarter reached $54.70M , beating expectations by +13.63%.
Dividend declared on 6 Jan 2022
A dividend of $0.16 per share was announced, adjusted to $0.16. The dividend was paid on 15 Mar 2022.
Earnings released on 4 Nov 2021
EPS came in at $1.87 surpassing the estimated $1.29 by +44.96%, while revenue for the quarter reached $35.84M , beating expectations by +24.00%.
Dividend declared on 1 Oct 2021
A dividend of $0.16 per share was announced, adjusted to $0.16. The dividend was paid on 15 Dec 2021.
Earnings released on 5 Aug 2021
EPS came in at $1.28 falling short of the estimated $1.36 by -5.88%, while revenue for the quarter reached $34.92M , meeting expectations.
Dividend declared on 6 Jul 2021
A dividend of $0.16 per share was announced, adjusted to $0.16. The dividend was paid on 15 Sept 2021.
Earnings released on 1 Jun 2021
EPS came in at $1.98 surpassing the estimated $1.48 by +33.78%, while revenue for the quarter reached $37.96M , beating expectations by +8.47%.
Dividend declared on 5 Apr 2021
A dividend of $0.16 per share was announced, adjusted to $0.16. The dividend was paid on 15 Jun 2021.
Earnings released on 3 Feb 2021
EPS came in at $1.46 falling short of the estimated $1.47 by -0.68%, while revenue for the quarter reached $34.17M , beating expectations by +5.34%.
Dividend declared on 5 Jan 2021
A dividend of $0.16 per share was announced, adjusted to $0.16. The dividend was paid on 15 Mar 2021.
Earnings released on 5 Nov 2020
EPS came in at $1.91 surpassing the estimated $1.07 by +78.50%, while revenue for the quarter reached $31.86M , beating expectations by +14.01K%.
Dividend declared on 1 Oct 2020
A dividend of $0.16 per share was announced, adjusted to $0.16. The dividend was paid on 15 Dec 2020.
MLAB Stock Performance
Access detailed MLAB performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.